Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Soiken HoldingsTSE:2385 -0.45%55 Earnings Yield (Joel Greenblatt) % is 65.36% as of Mar. 2026, which is 525% above its 10-year median of 10.45. GuruFocus rates TSE:2385 with a GF Score™ of 55/100 and a GF Value™ of 円111.55 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 1,344 Biotechnology companies, Soiken Holdings ranks better than 99.33% on this metric.
Soiken Holdings's Enterprise Value for the quarter that ended in Mar. 2026 was 円477 Mil.
Soiken Holdings's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was 円276 Mil. Soiken Holdings's Earnings Yield (Joel Greenblatt) for the quarter that ended in Mar. 2026 was 65.36%.
The historical rank and industry rank for Soiken Holdings's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:
TSE:2385'
s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: -2174.57 Med: 10.45 Max: 5915.51
Current: 152.65
During the past 13 years, the highest Earnings Yield (Joel Greenblatt) of Soiken Holdings was 5915.51%. The lowest was -2174.57%. And the median was 10.45%.
TSE:2385's Earnings Yield (Joel Greenblatt) % is ranked better than 99.33% of 1344
companies
in the Biotechnology industry
Industry Median: -10.02
vs TSE:2385: 152.65
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. Soiken Holdings's Forward Rate of Return (Yacktman) % for the quarter that ended in Mar. 2026 was 0.00%. The Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.
Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.
Be Aware
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
Soiken Holdings Earnings Yield (Joel Greenblatt) % Related Terms
Soiken Holdings Earnings Yield (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Soiken Holdings's Earnings Yield (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Soiken Holdings's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Soiken Holdings Earnings Yield (Joel Greenblatt) % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Soiken Holdings's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Soiken Holdings's Earnings Yield (Joel Greenblatt) % falls into.
In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.
Soiken Holdingss Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Jun. 2026 is calculated as
Soiken Holdings's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円276 Mil.
What does a Earnings Yield (Joel Greenblatt) % of 65.36% mean?
Soiken Holdings (TSE:2385) has a Earnings Yield (Joel Greenblatt) % of 65.36% as of Mar. 2026. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on Soiken Holdings and its competitors. This is 525% above median its historical median of 10.45. According to the industry distribution chart, Soiken Holdings ranks #9 out of 1344 companies in the Biotechnology industry, placing it in the top 0.7%.
Is Soiken Holdings' Earnings Yield (Joel Greenblatt) % too high?
Soiken Holdings' current Earnings Yield (Joel Greenblatt) % of 65.36% is 525% above median its 10-year median of 10.45. Based on the distribution chart, Soiken Holdings ranks #9 out of 1344 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Soiken Holdings has a GF Score™ of 55/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Soiken Holdings' Earnings Yield (Joel Greenblatt) % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Soiken Holdings ranks #9 out of 1344 companies for Earnings Yield (Joel Greenblatt) %. This places Soiken Holdings in the top 1% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings Yield (Joel Greenblatt) % for a Biotechnology company?
A good Earnings Yield (Joel Greenblatt) % depends on the Biotechnology industry context. However, Earnings Yield (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings Yield (Joel Greenblatt) % mean?
A high Earnings Yield (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on Soiken Holdings and its competitors. Soiken Holdings's current Earnings Yield (Joel Greenblatt) % is 65.36%, which is 525% above median its own 10-year median of 10.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Soiken Holdings stock overvalued right now?
Based on GuruFocus' analysis, Soiken Holdings (TSE:2385) is currently considered Significantly Overvalued. The stock's GF Value™ is 円111.55, compared to a current price of 円223.00 — trading 99.9% above its estimated fair value. The current Earnings Yield (Joel Greenblatt) % is 65.36%, which is 525% above median its 10-year median of 10.45. Soiken Holdings' overall GF Score™ is 55/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings Yield (Joel Greenblatt) % calculated?
Earnings Yield (Joel Greenblatt) % is calculated from a company's financial statements. For Soiken Holdings (TSE:2385), the current Earnings Yield (Joel Greenblatt) % is 65.36% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Soiken Holdings (TSE:2385) Overvalued in 2026?
Based on GuruFocus' analysis, Soiken Holdings stock appears to be overvalued.
The current stock price of 円223.00 is trading 99.9% above its estimated GF Value™ of 円111.55.
GuruFocus considers Soiken Holdings to be Significantly Overvalued.
Key valuation signals for TSE:2385:
Earnings Yield (Joel Greenblatt) %: 65.36% (525% above median its 10-year median of 10.45)
GF Value™: 円111.55 vs. price of 円223.00 (99.9% above fair value)
No single metric tells the full story. See the TSE:2385 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Soiken Holdings Inc operates as a biotechnology company in Japan. It provides clinical testing for pharmaceutical and food manufacturers that develop drugs and health food products based on biomarkers. It is involved in the marketing research and post-marketing surveillance of health supplements.
55GF Score
Get the complete analysis for TSE:2385
Earnings Yield (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:2385 has been successfully added to your 
